Richard Egen - Vasamed Director

VSMD Stock  USD 0.0001  0.00  0.00%   

Director

Richard B. Egen was Director of Optical Sensors since June 1997 since 1997.
Age 70
Tenure 27 years
Phone952-944-5857
Webhttps://www.vasamed.com
Egen currently serves as the Chairman of the Board of Directors of Aksys, Ltd. From January 1997 to July 2001, Mr. Egen served as President and Chief Executive Officer of NephRx Corporationrationrationration, an early stage biotechnology company. From January 1996 to December 1996, he served as a consultant to Baxter International, Inc. and Nestlé, S.A. for clinical nutrition and start up medical companies. From January 1989 to December 1995, he served as President and Chief Executive Officer of Clintec International, Inc., a joint venture between Baxter and Nestlé that develops, manufactures, markets and distributes clinical nutrition solutions and formulations. Prior to joining Clintec International, Inc., Mr. Egen served in several positions at Baxter, including Senior Vice President and a member of Baxter’s Senior Management Committee.

Vasamed Management Efficiency

The company has return on total asset (ROA) of (0.741) % which means that it has lost $0.741 on every $100 spent on assets. This is way below average. Vasamed's management efficiency ratios could be used to measure how well Vasamed manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 1.8 M in liabilities. Vasamed has a current ratio of 0.32, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vasamed until it has trouble settling it off, either with new capital or with free cash flow. So, Vasamed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vasamed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vasamed to invest in growth at high rates of return. When we think about Vasamed's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Stacey MobleyHP Inc
73
Mary CitrinoHP Inc
61
Aida AlvarezWalmart
65
Pamela CraigMerck Company
64
James SkinnerHP Inc
70
Robert KidderMerck Company
71
Linnet DeilyChevron Corp
72
Debra ReedKlagesChevron Corp
63
Ronald SugarChevron Corp
72
TimothyWalmart
58
Marissa MayerWalmart
44
Patricia RussoMerck Company
68
William HarrisonMerck Company
70
Charles MoormanChevron Corp
68
Carl BassHP Inc
58
Inge ThulinMerck Company
67
Stephen EasterbrookWalmart
50
Rochelle LazarusMerck Company
71
John StumpfChevron Corp
61
Wendell WeeksMerck Company
59
Shumeet BanerjiHP Inc
61
Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota. Vasamed operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. Vasamed [VSMD] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading.

Management Performance

Vasamed Leadership Team

Elected by the shareholders, the Vasamed's board of directors comprises two types of representatives: Vasamed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vasamed. The board's role is to monitor Vasamed's management team and ensure that shareholders' interests are well served. Vasamed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vasamed's outside directors are responsible for providing unbiased perspectives on the board's policies.
Terry Duesterhoeft, Vice President of Sales and Marketing
Andrew Jay, Director
Michael Schreiber, Pres CEO
Roberta Dircks, CFO and VP of Fin. and Admin.
Wesley Peterson, Sec
Daniel Bartnik, CTO Operations
Paulita LaPlante, CEO and President and Director
Charles Snead, Director
Kent Winger, VP of Operations and VP of Strategic Planning and Product Devel.
Richard Egen, Director
Craig Walker, Director

Vasamed Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Vasamed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vasamed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vasamed's short interest history, or implied volatility extrapolated from Vasamed options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vasamed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Vasamed Pink Sheet analysis

When running Vasamed's price analysis, check to measure Vasamed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vasamed is operating at the current time. Most of Vasamed's value examination focuses on studying past and present price action to predict the probability of Vasamed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vasamed's price. Additionally, you may evaluate how the addition of Vasamed to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Please note, there is a significant difference between Vasamed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vasamed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vasamed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.